We're A Little Worried About Arbutus Biopharma's (NASDAQ:ABUS) Cash Burn Rate [Yahoo! Finance News]
Arbutus Biopharma Corporation (ABUS)
Last arbutus biopharma corporation earnings: 11/6 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.arbutusbio.com/node/5806
Company Research
Source: Yahoo! Finance News
We're A Little Worried About Arbutus Biopharma's (NASDAQ:ABUS) Cash Burn Rate Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com? So, the natural question for Arbutus Biopharma NASDAQ:ABUS See our latest analysis for Arbutus Biopharma How Long Is Arbutus Biopharma's Cash Runway? A company's cash runway is calculated by dividing its cash hoard by its cash burn. In June 2019, Arbutus Biopharma had US$95m in cash, and was debt-free. In the last year, its cash burn was US$65m. That means it had a cash runway of around 18 months as of June 2019. That's not too bad, but it's fair to say the end of the cash runway is in sight
Show less
Read more
Impact Snapshot
Event Time:
ABUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABUS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABUS alerts
High impacting Arbutus Biopharma Corporation news events
Weekly update
A roundup of the hottest topics
ABUS
News
- Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Arbutus Biopharma Co. (NASDAQ: ABUS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $4.00 price target on the stock.MarketBeat
- Arbutus Biopharma First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]Yahoo! Finance
- Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024 [Yahoo! Finance]Yahoo! Finance
ABUS
Earnings
- 5/2/24 - In-Line
ABUS
Sec Filings
- 5/2/24 - Form 10-Q
- 5/2/24 - Form 8-K
- 5/2/24 - Form 8-K
- ABUS's page on the SEC website